Table 3 Logistic regression analysis of the factors associated with in-hospital mortality in all patients who underwent TAVI and SAVR in Spain, 2014/15

Charlson comorbidity index^a

1.60 (1.29–1.96)

Diabetes

0.60 (0.37–0.99)

Computerized tomography of the torax

1.85 (1.02–3.54)

Cardioversion

5.30 (2.42–11.60)

Hemodialysis

15.74 (8.08–30.64)

Red blood cell transfusion

1.96 (1.21–3.17)

Obesity

0.95 (0.55–2.26)

Female sex

1.33 (1.14–1.56)

Age groups (years)

 40–66

1

 67–75

1.57 (1.26–1.96)

 ≥ 76

2.68 (2.17–3.31)

Charlson comorbidity index^a

1.61 (1.49–1.74)

Atrial fibrillation

0.67 (0.57–0.79)

Diabetes

0.80 (0.66–0.96)

Endocarditis

2.13 (1.62–2.79)

Hypertension

0.64 (0.54–0.75)

Lipid metabolism disorders

0.81 (0.68–0.97)

Smoking

0.60 (0.48–0.76)

Computerized tomography of the torax

2.03 (1.57–2.62)

Pacemaker device implantation

0.68 (0.47–0.99)

Cardioversion

1.53 (1.17–2.00)

Balloon counterpulsation

11.11 (8.50–14.52)

Hemodialysis

9.98 (8.02–12.40)

Red blood cell transfusion

1.71 (1.46–1.99)

Postoperative infection

2.28 (1.75–2.97)

Length of stay

0.98 (0.97–0.99)

Obesity

0.92 (0.71–1.20)